Next-generation ctDNA-driven clinical trials in precision immuno-oncology
Saved in:
Main Authors: | Charu Aggarwal, Natasha B Leighl |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-01-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/11/1/e006397.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Precision oncology through next generation sequencing in hepatocellular carcinoma
by: Sayali Shinde, et al.
Published: (2025-02-01) -
Clinical characteristics of EGFR-ctDNA shedders in EGFR-mutant NSCLC patients
by: Martina Ruglioni, et al.
Published: (2025-02-01) -
The Utility of Circulating Tumor DNA (ctDNA) Monitoring in Cancer Patients Who Are Pregnant or Planning to Become Pregnant
by: Stacey A. Cohen, et al.
Published: (2022-01-01) -
The hype around ctDNA guiding an informed perioperative therapeutic strategy in early-stage non-small cell lung cancer
by: Gaia Passarella, et al.
Published: (2025-01-01) -
Leveraging mRNA technology for antigen based immuno-oncology therapies
by: Wei Zheng, et al.
Published: (2025-01-01)